Literature DB >> 17032656

Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro.

Dean Clarke1, Stephen Griffin, Lucy Beales, Corine St Gelais, Stan Burgess, Mark Harris, David Rowlands.   

Abstract

The p7 protein of hepatitis C virus functions as an ion channel both in vitro and in cell-based assays and is inhibited by amantadine, long alkyl chain imino-sugar derivatives, and amiloride compounds. Future drug design will be greatly aided by information on the stoichiometry and high resolution structure of p7 ion channel complexes. Here, we have refined a bacterial expression system for p7 based on a glutathione S-transferase fusion methodology that circumvents the inherent problems of hydrophobic protein purification and the limitations of chemical synthesis. Rotational averaging and harmonic analysis of transmission electron micrographs of glutathione S-transferase-FLAG-p7 fusion proteins in liposomes revealed a heptameric stoichiometry. The oligomerization of p7 protein was then confirmed by SDS-PAGE and mass spectrometry analysis of pure, concentrated FLAG-p7. The same protein was also confirmed to function as an ion channel in suspended lipid bilayers and was inhibited by amantadine. These data validate this system as a means of generating high resolution structural information on the p7 ion channel complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17032656     DOI: 10.1074/jbc.M602434200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels.

Authors:  Siok-Wan Gan; Edward Tan; Xin Lin; Dejie Yu; Juejin Wang; Gregory Ming-Yeong Tan; Ardcharaporn Vararattanavech; Chiew Ying Yeo; Cin Huang Soon; Tuck Wah Soong; Konstantin Pervushin; Jaume Torres
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

2.  NMR structure and ion channel activity of the p7 protein from hepatitis C virus.

Authors:  Roland Montserret; Nathalie Saint; Christophe Vanbelle; Andrés Gerardo Salvay; Jean-Pierre Simorre; Christine Ebel; Nicolas Sapay; Jean-Guillaume Renisio; Anja Böckmann; Eike Steinmann; Thomas Pietschmann; Jean Dubuisson; Christophe Chipot; François Penin
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

Review 3.  Ion channels as antivirus targets.

Authors:  Xin Liang; Zhi-Yuan Li
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

Review 4.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

5.  Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant.

Authors:  Artur Kaul; Ilka Woerz; Philip Meuleman; Geert Leroux-Roels; Ralf Bartenschlager
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

6.  Determination of pore-lining residues in the hepatitis C virus p7 protein.

Authors:  Chee Foong Chew; Ranjit Vijayan; Jason Chang; Nicole Zitzmann; Philip C Biggin
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

7.  Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Francisco N Barrera; Olga Potapova; Donald M Engelman; Anna M Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

8.  Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.

Authors:  Ulrike Breitinger; Noha S Farag; Nourhan K M Ali; Hans-Georg A Breitinger
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

9.  A synthetic S6 segment derived from KvAP channel self-assembles, permeabilizes lipid vesicles, and exhibits ion channel activity in bilayer lipid membrane.

Authors:  Richa Verma; Chetan Malik; Sarfuddin Azmi; Saurabh Srivastava; Subhendu Ghosh; Jimut Kanti Ghosh
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

10.  A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.

Authors:  Jorge Méndez-Navarro; Ruby A Chirino; Kathleen E Corey; Emmanuel C Gorospe; Hui Zheng; Segundo Morán; Jesus A Juarez; Raymond T Chung; Margarita Dehesa-Violante
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.